![Petra Budde](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Petra Budde
Directeur Technique/Scientifique/R&D chez
ONCE HLDG
Profil
Petra Budde currently works at Oncimmune Holdings Plc, as Chief Scientific Officer from 2023.
Postes actifs de Petra Budde
| Sociétés | Poste | Début |
|---|---|---|
| ONCE HLDG | Directeur Technique/Scientifique/R&D | 01/01/2023 |
Oncimmune Germany GmbH
 Oncimmune Germany GmbH BiotechnologyHealth Technology Develops antibody and autoantibody biomarker discovery platform | Directeur Technique/Scientifique/R&D | 01/01/2023 |
Anciens postes connus de Petra Budde
| Sociétés | Poste | Fin |
|---|---|---|
Protagen AG
 Protagen AG BiotechnologyHealth Technology Specializes in the development of novel diagnostic and companion diagnostic tests | Directeur Technique/Scientifique/R&D | 01/01/2019 |
Formation de Petra Budde
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
8
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
University of Bielefeld
 University of Bielefeld Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Protagen AG
Protagen AG BiotechnologyHealth Technology Specializes in the development of novel diagnostic and companion diagnostic tests | Health Technology |
Oncimmune Holdings Plc
 Oncimmune Holdings Plc BiotechnologyHealth Technology Provides cancer detection and diagnosis services | Health Technology |
Oncimmune Germany GmbH
Oncimmune Germany GmbH BiotechnologyHealth Technology Develops antibody and autoantibody biomarker discovery platform | Health Technology |
